Effects of Mask Reuse on the Oropharyngeal, Skin, and Mask Microbiome

Evaluation of the penetration capacity of bacteria through layers of different face mask types and wearing conditions

The aim of this study was to quantify the number of non-airborne bacteria that can passively penetrate the layers of four mask types (surgical mask, community face mask type 1 (CFM1), biocidal CFM1 and CFM2) and to determine the influence of wearing conditions for the surgical type. A mask wearer simulator consisting of a 3D anatomical replica of the upper airway connected to a breathing pump was used. Wearing time, filtration quality of the mask, fit (loose vs. tight) and breathing parameters (tidal volume, respiratory rate) were tested. A Staphylococcus epidermidis inoculum was applied to the inner layer. After the wearing simulation, the layers were separated and the bacteria counted. After four hours, no or only a few bacteria were present in the middle and outer layers. Most remained in the inner layer. Surgical mask and CFM1 retained more bacteria and provided a breeding ground for germs. The biocidal CFM1 rapidly reduced the number in the inner layer. The breathing parameters had no influence, in contrast to fit and wearing time. These results confirm that the standard test for bacterial filtration efficiency, which includes the active penetration of airborne bacteria into aerosol droplets, is the most objective measure of the ability of bacteria to penetrate through the mask layers, as the passive penetration ability of non-airborne bacteria is insignificant.

Efficacy of a moisturizing cream and facial mask for alleviating skin problems associated with medical mask use: A half-face, randomized controlled study

BACKGROUND

Prolonged use of medical masks has increased skin-related issues.

AIM

To evaluate the efficacy of a facial cream and facial mask in mitigating medical mask related skin symptoms.

METHODS

Healthy women were randomly assigned to apply a facial cream (n = 32) or a facial mask plus a facial cream (n = 32) on half-faces after wearing medical masks for 4 h (Tb). Transepidermal water loss (TEWL), dryness score, and redness area were assessed at Tb and 10 min after using the cream (T1) in the facial cream group, and at Tb, 1 h after using the facial mask (T2), and 10 min after using the cream (T3) in the combined use group.

RESULTS

In the facial cream group, the treated half-face showed significantly better improvements from Tb to T1 in TEWL (-2.95 ± 0.38 vs. -0.68 ± 0.35 g/h·cm2, p < 0.001) and skin dryness score (-1.00 ± 0.12 vs. 0.00 ± 0.00, p < 0.001). In the combined use group, the treated half-face showed significantly better improvements from Tb to T2 and T3 in TEWL (T2, -3.46 ± 0.33 vs. -0.09 ± 0.13 g/h·cm2; T3, -4.67 ± 0.31 vs. -0.28 ± 0.22 g/h·cm2) and skin dryness score (T2, -0.63 ± 0.13 vs. 0.03 ± 0.03; T3, -0.94 ± 0.17 vs. 0.19 ± 0.07) (all p < 0.001) then the untreated half-face. The combined use group had significantly lower TEWL at T3 than T2 (p < 0.05). The reduction in redness area was similar between the treated and untreated half-faces in both groups.

CONCLUSIONS

The test facial cream and mask significantly improved skin barrier function and alleviated dryness symptoms associated with medical mask use, with the combined use offering superior benefits.